Navigation Links
BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
Date:4/26/2008

DE (n=1) and 12 percent of

patients receiving adefovir (n=5) experienced a serious adverse event.

-- No deaths were observed in either treatment group.

-- No patients in the BARACLUDE arm and one patient in the adefovir arm

experienced an ALT flare (defined as ALT greater than two times

baseline and greater than 10 times the upper limit of normal).

About the Study

The E.A.R.L.Y. study (ETV-079) is a randomized, open-label, comparative viral kinetics study of antiviral-naive chronic HBeAg-positive patients evaluating antiviral activity as measured by mean reduction in viral load, or levels of hepatitis B virus (HBV DNA) in the blood. HBeAg or e-antigen, is a viral protein associated with hepatitis B infections, and is found in the blood only when there is virus present.

The primary endpoint for the study was mean reduction in HBV DNA levels at week 12. The secondary endpoints included the mean change in viral load from baseline through week 96, the proportion of patients in each treatment group who achieved ALT normalization, HBeAg loss and HBe seroconversion, and safety.

Sixty-nine patients were randomized in the study and of these, 65 completed the first 12 weeks. Patients in this study received either 0.5 mg of BARACLUDE(R) (entecavir) once daily (n=33) or 10 mg of adefovir once daily (n=32) for a minimum of 52 weeks. Patients in the BARACLUDE treatment group had a mean baseline viral load of 10.26 log(10) copies/mL. Patients in the adefovir treatment group had a mean baseline viral load of 9.88 log(10) copies/mL.

According to study protocol, patients who achieved a treatment response at 52 weeks discontinued treatment and entered a follow-up monitoring phase. Three BARACLUDE-treated patients and four adefovir-treated patients met this criterion and entered the follow-up monitoring phase lasting up to 48 weeks. Patients who did not achieve a treatment response at 52 weeks continued on study
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
2. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
3. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
8. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
9. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
10. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
11. Many Heart Attack Patients Dont Get Best Emergency Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2015)... -- Introduction of new "Elements" ... for radiosurgery/SBRT   The "Elements" strategy ... the workflow for difficult to treat indications in ... comes full circle with the introduction of automated ... enable on-the-fly generation of consistent treatment plans for ...
(Date:4/24/2015)... T-Bird Pharma Inc. (TSXV:TPI) ("T-Bird" or the "Company"), a ... products and a licensed producer ("LP") to cultivate marijuana ... Canada ) ("MMPR"), is pleased to announce that ... the transaction announced on March 11, 2015 with Medna ... a total of 20,156,790 common shares of T-Bird (45% ...
(Date:4/23/2015)... Lifesciences Corporation (NYSE: EW ), the global leader ... today reported net income for the quarter ended March 31, ... Net income for the same period a year earlier ... non-GAAP net income was $82.1 million, or $0.76 per ... ended March 31, 2015 increased 13.0 percent to $590.3 million ...
Breaking Medicine Technology:Brainlab Introduces New Generation of VMAT* for Brain and Spine at 3rd ESTRO in Barcelona 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 2T-Bird Pharma Inc. Announces Closing of Transaction with Medna Biosciences 3Edwards Lifesciences Reports First Quarter Results 2Edwards Lifesciences Reports First Quarter Results 3Edwards Lifesciences Reports First Quarter Results 4Edwards Lifesciences Reports First Quarter Results 5Edwards Lifesciences Reports First Quarter Results 6Edwards Lifesciences Reports First Quarter Results 7Edwards Lifesciences Reports First Quarter Results 8Edwards Lifesciences Reports First Quarter Results 9Edwards Lifesciences Reports First Quarter Results 10Edwards Lifesciences Reports First Quarter Results 11Edwards Lifesciences Reports First Quarter Results 12Edwards Lifesciences Reports First Quarter Results 13Edwards Lifesciences Reports First Quarter Results 14Edwards Lifesciences Reports First Quarter Results 15Edwards Lifesciences Reports First Quarter Results 16
... spinal company continues to focus on unmet needs of the lumbar ... ... disc, MINNEAPOLIS, May 1 CoreSpine Technologies, LLC, an,emerging spinal ... implant procedures to include an application,for minimally invasive fusion., The ...
... predict life-long tendency to inflammation ... related cardiovascular event risk profile, WALTHAM, Mass., May ... announced publication of the results of clinical,studies that support ... The article, titled, "IL1B Gene Promoter Haplotype,Pairs Predict Clinical ...
Cached Medicine Technology:CoreSpine Technologies Expands Spinal Disc Site Preparation Efforts 2Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test 2Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test 3Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test 4Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics' Heart Health Test 5
(Date:4/25/2015)... 2015 The Hon. Ellen Tauscher, Independent ... the following statement following the deadly earthquake in Nepal: ... resulting in the deaths of more than 1,000 people. ... across Nepal, Bangladesh, India and other parts of South ... to the people of Nepal and the families of ...
(Date:4/25/2015)... (PRWEB) April 25, 2015 Carinsurancequotesinfo.com has ... find low cost auto insurance for flatbed ... heavy goods and sometimes other vehicles. They are mainly ... insurance. The newly released blog post explains that by ... for trucks, vans and other commercial vehicles. , It ...
(Date:4/25/2015)... 25, 2015 An expanded and newly ... of successfully welcoming visitors to the Turks and Caicos ... As part of a major construction project occurring in ... redesigned to speed up arrivals. A new exterior ... out of the airport and onto Grace Bay beach! ...
(Date:4/25/2015)... New York (PRWEB) April 25, 2015 The ... Dr. Jerry Blaivas has been chosen by the New York ... his contributions to medicine in the field of Urology. , ... best in his speciality, Genito-Urinary diseases. He was a ... in the field of urology. Not only did he ...
(Date:4/25/2015)... 2015 For thirteen years, the Twin Cities ... education event in the nation! This year, on May 5th, ... US to take DI Day on the road by supporting ... CLU, ChFC, RHU, DIA, CLTC, Chief Executive Officer at Secura ... on the change by stating, "The first Twin Cities DI ...
Breaking Medicine News(10 mins):Health News:Auto Insurance Quotes for Flatbed Trucks Available Online! 2Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 2Health News:The 2015 Valentine Award Comes From The Heart and Goes To Famous New York Urologist 3Health News:Secura Consultants Takes DI Day On The Road 2
... words today throughout the country are 'Dengue' and ... the bite of an infected// Aedes aegypti female ... states. Dengue is the most common mosquito-borne viral ... administrative machinery is battling with a situation that is threatening ...
... normally used to treat ulcers, was found to prevent ... women in developing countries, according// to a study conducted ... India's Jawaharlal Nehru Medical College, and the National Institutes ... Oct. 8 issue of Lancet, found misoprostol reduced the ...
... pregnant women suffering from malaria was found to be safe ... and at the London School of Hygiene & Tropical Medicine ... the malarial parasite without any serious side effects in the ... only with the drug amodiaquine or in combination with sulphadoxine-pyrimethamine ...
... of bowel cancer is greater among women than among men ... a Sydney study that was carried on 1200 bowel cancer ... likely to die from their disease compared to males. On ... aged 50 and under actually had a better survival rate ...
... of stroke in Perth, Western Australia by 43% over the ... George Institute for International Health at the Annual Scientific Meeting ... ,Stroke affects around 17 million people globally and is ... Nationally, over 53,000 strokes occur each year, of which one ...
... in the HIV/AIDS prevalence rate in Kenya from 6.1% in ... Control Council of Kenya (NACC) released the latest data, according ... 9.6 % whereas in rural areas it is 4.6%.,A variety ... preventing pregnant HIV-positive mothers from passing the virus to their ...
Cached Medicine News:Health News:Dengue and Chikungunya: The Dirge of a Nation 2Health News:Dengue and Chikungunya: The Dirge of a Nation 3Health News:Dengue and Chikungunya: The Dirge of a Nation 4Health News:Ulcer Drug Could Save Lives of Women in Developing Countries 2Health News:New method to treat malaria in pregnant women 2Health News:Increased Risk of Bowel cancer after Menopause 2Health News:Declining Incidence of stroke in Australia 2Health News:Decrease in AIDS prevalence rate in Kenya 2
... Unparalleled Comfort Pick one of our pipettors ... the trigger and ejector positionsright where they should ... are ergonomically designed to help avoid repetitive stress ... Productivity In The Palm Of Your Hand ...
... for Unparalleled Comfort Pick one of our ... Notice the trigger and ejector positionsright where they ... pipettors are ergonomically designed to help avoid repetitive ... Productivity In The Palm Of Your Hand ...
... Ergonomic Design for Unparalleled Comfort Pick ... Notice the balance. Notice the trigger and ejector ... Thats because our pipettors are ergonomically designed to ... hours of pipetting. Productivity In The Palm ...
... The total ergonomic solution and best value ... feather touch action and ultra lightweight design ... tip ejection with long, lever tip ejector ... , Accepts universal tips or for greater ...
Medicine Products: